Table 1 PI3K–AKT activating mutations and their coexistence in 97 endometrial cancers

From: The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas

 

n (%)

Wild-type

24 (25)

AKT1 mutation alone

2 (2)

K-Ras mutation alone

4 (4)

PIK3CA mutation alone

6 (6)

PTEN mutation alone

30 (31)

Double mutations of K-Ras and PIK3CA (w/o PTEN mutation)

2 (2)

Double mutations of K-Ras and PTEN (w/o PIK3CA mutation)

3 (3)

Double mutations of PIK3CA and PTEN (w/o K-Ras mutation)

18 (19)

Triple mutations of K-Ras, PIK3CA and PTEN

8 (8)

  1. PI3K, phosphatidylinositol 3′-kinase.
  2. Wild-type, no mutations in PTEN, PIK3CA, K-Ras and AKT1.